ADC Therapeutics (ADCT)
(Delayed Data from NYSE)
$4.34 USD
-0.10 (-2.25%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $4.34 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.58 |
EPS Last Quarter | -1.03 |
Last EPS Surprise | -119.15% |
ABR | 1.86 |
Earnings ESP
|
4.00% |
---|---|
Current Year | -2.20 |
Next Year | -1.59 |
EPS (TTM) | -2.93 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 18.40M | 20.01M | 83.22M | 102.28M |
# of Estimates | 3 | 3 | 4 | 3 |
High Estimate | 18.85M | 20.70M | 91.87M | 108.23M |
Low Estimate | 17.66M | 19.04M | 76.69M | 97.01M |
Year ago Sales | 18.99M | 19.28M | 69.56M | 83.22M |
Year over Year Growth Est. | -3.09% | 3.79% | 19.64% | 22.90% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.58 | -0.58 | -2.20 | -1.59 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -0.56 | -0.58 | -2.33 | -1.72 |
High Estimate | -0.53 | -0.51 | -1.89 | -1.51 |
Low Estimate | -0.66 | -0.65 | -2.53 | -1.72 |
Year ago EPS | -0.74 | -0.58 | -2.94 | -2.20 |
Year over Year Growth Est. | 21.62% | 0.00% | 25.17% | 27.35% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 0 |
Down Last 60 Days | 2 | 2 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.58 | -0.58 | -2.20 | -1.59 |
7 Days Ago | -0.58 | -0.58 | -2.20 | -1.59 |
30 Days Ago | -0.58 | -0.57 | -2.19 | -1.64 |
60 Days Ago | -0.47 | -0.47 | -1.92 | -1.49 |
90 Days Ago | -0.48 | -0.34 | -1.91 | -1.30 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.56 | -0.62 | -2.43 | -1.55 |
Zacks Consensus Estimate | -0.58 | -0.58 | -2.20 | -1.59 |
Earnings ESP | 4.00% | -6.03% | -10.71% | 2.72% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.03 | -0.58 | -0.58 | -0.74 | NA |
Estimate | -0.47 | -0.61 | -0.44 | -0.80 | NA |
Difference | -0.56 | 0.03 | -0.14 | 0.06 | -0.15 |
Surprise | -119.15% | 4.92% | -31.82% | 7.50% | -34.64% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more